Kiniksa Pharmaceuticals Ltd (KNSA)
$21.25 -$0.30 (-1.40%) 4:38 PM 12/11/24
NASDAQ | $USD | Drug Manufacturers - Specialty & GenericStock Data
-
Market Cap
$1.55B -
Day's Range
$21.04 - $21.48 -
Volume
254,292 -
52 Week Low / High
$16.56 - $28.15 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
KNSA's Dividend
Hypothetical 10k Investment Jan 1, 2020
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
Analyists Ranking
- 4
- Strong Buy
- 2
- Buy
- 0
- Hold
- 0
- Sell
- 0
- Strong Sell
- $25.40
- Target Price
Company News
-
Roth analysis: Has volatility created a trigger warning for stocks? — Aug 12th, 2024
Investing.com - The financial markets have experienced a roller coaster ride of late, prompting analysts at Roth to issue a technical strategy update. Despite ending last week down just 0.04%, the S&P 500's minor dip feels like a victory considering Monday’s significant 3% plunge. In co...
|
Portfolio
$5,000/year
Goal: $10,000/year
Comprised of 1 portfolios
$